Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (514)	11/23/2004 5:36:41 PM
From: Biomaven	Read Replies (2) of 625

I emailed them and got sent a bunch of documents a few hours later (with apologies for the delay!) A very brief look at them (the one weirdly titled "04 - metadata stripped redacted" is the key one) lays out CATG's case. Seems pretty convincing on a very quick read - but then of course I haven't read Abbott's response. In particular Abbott threw in the kitchen sink in terms of royalty payments, including some apparently quite unrelated to the CATG patent. My instinct (and it's no more than that) is that at very least CATG will improve on 2%. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next